Skip to content

Real-World Study of da Vinci Robotic Kamikawa Surgery for Early Upper Gastric Cancer

Real-World Study of da Vinci Robotic Kamikawa Surgery for Early Upper Gastric Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500099266
Enrollment
Unknown
Registered
2025-03-20
Start date
2025-04-01
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early-stage upper gastric cancer

Interventions

Inculsion group (Using the da Vinci robotic Kamikawa surgical approach to treat early-stage upper gastric cancer):None

Sponsors

Renji Hospital , Shanghai Jiao Tong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 18 years < age < 75 years; Gastric adenocarcinoma confirmed by postoperative pathological examination following gastrectomy

Exclusion criteria

Exclusion criteria: Pregnant or breastfeeding women History of other malignant diseases within the past 5 years Gastric cancer patients who have undergone or are recommended for neoadjuvant therapy History of unstable angina or myocardial infarction within the past 6 months History of cerebral infarction or cerebral hemorrhage within the past 6 months History of continuous systemic corticosteroid treatment within the past 1 month Requiring concurrent surgical treatment for other diseases

Design outcomes

Primary

MeasureTime frame
Tumor Location;Pathological staging(pT,pN,pM );Neoadjuvant Chemotherapy;Surgical Approach;Extent of Resection;Reconstruction Method;Lymphovascular Invasion;Perineural Invasion;Number of Lymph Node Metastases;Number of Lymph Nodes Dissected;Ki67 Index;P53;HER2;PD-L1;Survival Time;

Secondary

MeasureTime frame
Sex;Age;

Countries

China

Contacts

Public ContactXiang Xia

Renji Hospital , Shanghai Jiao Tong University School of Medicine

xiangmoumou@163.com+86 136 5181 0863

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026